Galileo Life Sciences, Inc. Announces Board and Management Changes

Galileo Life Sciences (“the Company”) (PINKSHEETS:MDRM) announced that it has strengthened its Board of Directors with the appointment of three new members and accepted the resignation of Kenneth Pinckard as CEO and member of the Board of Directors.

The three new Directors include: Dr. Baseer Khan, an internationally recognized surgeon, researcher and consultant, who is currently a member of the Galileo Life Sciences Medical Advisory Board; John M. Rosenthal, a senior partner of RZN, LLP Chartered Professional Accountants and Licensed Public Accountants; and Kenneth Pham, a finance and operations professional with over 15 year of experience in the private and public sector. Preston J. Shea, President, Treasurer and Secretary of Galileo Life Sciences represents the fourth member of the Board of Directors.

Dr. Khan has been appointed CEO of Galileo Life Sciences, effective immediately.

“Galileo Life Sciences is at the forefront of the dynamic new medical marijuana industry in Canada and committed to leading edge research and development in support of rapidly growing alternative health and life sciences trends and technologies. I look forward to working with the management team and my fellow Board members to fuel the profitable growth of our company,” stated Dr. Khan.

More details on these Board and Management changes are available in the recently filed 8K.

About Galileo Life Sciences, Inc.

Galileo Life Sciences, Inc., formerly known as Modern Mobility Aids, is a company strategically focused on the production and distribution of premium medical marijuana in North America and advanced health and life science and services that nurture innovative solutions to enhance the quality of life for all. The Company also has a commitment to leading edge research and development in support of these rapidly growing alternative health and life sciences trends, technologies and services. Galileo Life Sciences, (formerly Modern Mobility Aids, Inc.) is listed on the New York OTC Pink Market and is currently trading under the ticker symbol MDRM.

For more information please contact:
Galileo Life Sciences, Inc.
Preston J. Shea
President, Treasurer and Secretary
Email: p.shea@galileolifesciences.com
Tel: 416-642-2593

Posted in: Press

Comments are closed.